ABSTRACT
Cancer antigen 125 (CA-125) is expressed by malignant human ovarian surface epithelial cells and derivatives of the Müllerian duct system. This study explored the expression, regulation, and function of CA-125 in the bovine uterus. CA-125 was localized by immunohistochemistry to the apical surfaces of epithelial cells lining the endometrium and proximal glands of the late luteal phase and early pregnancy; antigen was not detected during oestrus or the postpartum period. Production of CA-125 by bovine endometrial cells in vitro was upregulated by progesterone and interferon-tau. Immunopurified CA-125 from uterine flushes of dioestrous or pregnant cows was similar in biochemical composition (as determined by gel electrophoresis and amino acid content) to the human antigen isolated from incubation medium conditioned by the ovarian cancer cell line OVCAR-3. Bovine CA-125 inhibited complement-induced lysis of antibody-sensitized sheep erythrocytes. It is suggested that endometrial CA-125 exerts a progestational role in part by protecting maternal and embryonic cells from immune targeting and lysis.
Subject(s)
CA-125 Antigen/analysis , Cattle/metabolism , Endometrium/chemistry , Estrus/metabolism , Postpartum Period/metabolism , Pregnancy, Animal/metabolism , Amino Acids/analysis , Animals , CA-125 Antigen/chemistry , CA-125 Antigen/metabolism , Cells, Cultured , Endometrium/metabolism , Estradiol/pharmacology , Female , Immunohistochemistry/methods , Interferon Type I/pharmacology , Pregnancy , Pregnancy Proteins/pharmacology , Progesterone/pharmacologyABSTRACT
Oxidative base (8-oxoguanine) damage, DNA fragmentation, and apoptosis occurred among ovarian surface epithelial cells within the formative site of ovulation in sheep. The incidence of 8-oxoguanine adducts in surviving antiapoptotic Bcl-2/base excision repair polymerase beta-positive cells at the margins of ruptured follicles (which avoid the focal point of the ovulatory assault) was intermediate between apoptotic and outlying healthy epithelium. Cells containing perturbations to DNA expressed the tumor suppressor p53. Localized reactions of DNA injury and programmed cellular death were averted by ovulation blockade with indomethacin. Progesterone enhanced the biosynthesis of polymerase beta in ovarian surface epithelial cells exposed in vitro to a sublethal concentration of H(2)O(2). Ovulation is a putative etiological factor in common epithelial ovarian cancer. A genetically altered progenitor cell, with unrepaired DNA, but not committed to death, could give rise to a transformed phenotype that is hence propagated upon healing of the ovulatory wound; it appears that this incongruity is normally reconciled by up-regulation of the base excision repair pathway during the ensuing luteal phase.
Subject(s)
Apoptosis , DNA Damage , DNA Repair , Guanine/analogs & derivatives , Ovary/chemistry , Ovulation , Sheep , Animals , DNA Adducts , DNA Fragmentation , DNA Polymerase beta/analysis , DNA Polymerase beta/metabolism , Epithelial Cells/chemistry , Epithelial Cells/drug effects , Epithelial Cells/enzymology , Female , Gene Expression , Genes, p53/genetics , Guanine/analysis , Hydrogen Peroxide/pharmacology , Indomethacin/pharmacology , Ovarian Follicle/chemistry , Ovary/drug effects , Ovulation/drug effects , Progesterone/pharmacology , Proto-Oncogene Proteins c-bcl-2/analysis , Tumor Suppressor Protein p53/analysisABSTRACT
Urokinase plasminogen activator (uPA) has been implicated in the metastatic potential of ovarian carcinomas of surface epithelial origin. The SKOV-3 human ovarian cancer cell line was tested for uPA secretory responses (enzyme immunoassay of conditioned media) after treatments with sex steroids, human menopausal gonadotropins (hMG), or gonadotropin-releasing hormone (GnRH). Secretion of uPA during a 6-h incubation was unaffected by testosterone, estradiol-17beta, hMG, or GnRH. Progesterone, at supraphysiological concentrations, suppressed uPA secretion; this reaction was not altered by the progesterone receptor antagonist RU486 or the transcriptional inhibitor actinomycin D. It appears that progesterone exerted a direct biophysical effect on the plasma membrane manifested by an interference with shedding of uPA in exocytotic vesicles. Finally, invasion of SKOV-3 cells into Matrigel was inhibited by progesterone. We suggest that progesterone can disrupt the fluid dynamics of plasma membranes and thereby invoke an antitumorigenic action via inhibition of proteolytic secretions.
